Evidence map›Paper›PMID 36051610›Full record

ArticleExploratory research in clinical and social pharmacy2022

Development of a community pharmacy-based intervention for patients with uncontrolled asthma.

Claudie Turcotte, Rébecca Fénélon-Dimanche, Catherine Lemière, Marie-France Beauchesne, Bachir Abou-Atmé, Isabelle Chabot, Lucie Blais

Open access · goldAbstract read
In one paragraph

Article in Exploratory research in clinical and social pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Claudie TurcotteFaculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada.
Rébecca Fénélon-DimancheFaculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada.
Catherine LemièreResearch Centre, CIUSSS du Nord-de-l'île de Montréal, Montréal, Québec, Canada.
Marie-France BeauchesneFaculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada.
Bachir Abou-AtméFaculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada.
Isabelle ChabotFaculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada.
Lucie BlaisFaculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada.
Université de Montréal · CACentre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Achieving asthma control is often difficult, despite the availability of effective medications. Because of their expertise, regular contact with patients, and accessibility, community pharmacists can play an important role in helping patients manage uncontrolled asthma. Objective: To develop a community pharmacy-based intervention for improving asthma control in patients with uncontrolled moderate to severe asthma. Methods: A qualitative study involving two focus groups with six and five community pharmacists, respectively, five individual interviews with community pharmacists, and three individual interviews with asthma patients was conducted using semi-structured interview guides. Focus groups aimed to develop the first prototype of the intervention and the topics included criteria to identify patients with uncontrolled asthma, content of the intervention to manage uncontrolled asthma, and potential logistical issues. Interviews were subsequently conducted with individual pharmacists and asthma patients to evaluate the prototype and finalize the intervention. The interviews and focus group transcripts were analyzed thematically, using an iterative process. Results: In focus groups and interviews, the pharmacists discussed how they screen patients with uncontrolled asthma using prescriptions refills, their needs for a convenient tool to assess asthma control, the necessity to identify causes of uncontrolled asthma to guide asthma management strategies, and the importance of patient follow-up. During interviews, patients shared their interest for the commitment of pharmacists to managing asthma. The final intervention consists of structured face-to-face counselling sessions at community pharmacies, with six steps: screening of patients with potential uncontrolled moderate to severe asthma, assessment of asthma control, identification of the causes of uncontrolled asthma, strategies for controlling asthma, an optional follow-up at the next prescription refill, and a follow-up 3 months after the initial intervention. Conclusions: The patients and community pharmacists reached consensus on the intervention's key elements and provided support for implementing the intervention in community pharmacies.

Indexed as

ACT, Asthma Control TestAsthmaCommunity pharmacyCP, community pharmacistFG, focus groupIntervention developmentPharmacy practiceQualitative researchRESP, Registre de données en Santé PulmonaireSABA, short-acting β2-agonists

Identifiers

PMID36051610
PMCPMC9424560
OpenAlexW4294221649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.